Cargando…

Does amyloid deposition produce a specific atrophic signature in cognitively normal subjects?()

The objective of our study was to evaluate whether cognitively normal (CN) elderly participants showing elevated cortical beta-amyloid (Aβ) deposition have a consistent neuroanatomical signature of brain atrophy that may characterize preclinical Alzheimer's disease (AD). 115 CN participants who...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whitwell, Jennifer L., Tosakulwong, Nirubol, Weigand, Stephen D., Senjem, Matthew L., Lowe, Val J., Gunter, Jeffrey L., Boeve, Bradley F., Knopman, David S., Dickerson, Bradford C., Petersen, Ronald C., Jack, Clifford R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778266/ https://www.ncbi.nlm.nih.gov/pubmed/24179779 http://dx.doi.org/10.1016/j.nicl.2013.01.006

Ejemplares similares

Considerations for Performing Level-2 Centiloid Transformations for Amyloid PET SUVR values
por: Schwarz, Christopher G., et al.
Publicado: (2018)

Clinical and MRI models predicting amyloid deposition in progressive aphasia and apraxia of speech
por: Whitwell, Jennifer L., et al.
Publicado: (2016)

MRI and flortaucipir relationships in Alzheimer's phenotypes are heterogeneous
por: Josephs, Keith A., et al.
Publicado: (2020)

A Comparison of Partial Volume Correction Techniques for Measuring Change in Serial Amyloid PET SUVR
por: Schwarz, Christopher G., et al.
Publicado: (2019)

Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition
por: Vemuri, Prashanthi, et al.
Publicado: (2016)

FDG PET and MRI in Logopenic Primary Progressive Aphasia versus Dementia of the Alzheimer’s Type
por: Madhavan, Ajay, et al.
Publicado: (2013)

Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition
por: Kantarci, Kejal, et al.
Publicado: (2016)

AV‐1451 tau and β‐amyloid positron emission tomography imaging in dementia with Lewy bodies
por: Kantarci, Kejal, et al.
Publicado: (2016)

Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration
por: Jack, Clifford R., et al.
Publicado: (2014)

Contributions of imprecision in PET‐MRI rigid registration to imprecision in amyloid PET SUVR measurements
por: Schwarz, Christopher G., et al.
Publicado: (2017)

Rates of hippocampal atrophy and post-mortem TDP-43 in Alzheimer’s disease: a longitudinal retrospective study
por: Josephs, Keith A., et al.
Publicado: (2017)

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease
por: Jack, Clifford R., et al.
Publicado: (2009)

TDP-43-associated atrophy in brains with and without frontotemporal lobar degeneration
por: Buciuc, Marina, et al.
Publicado: (2022)

Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings
por: Jack, Clifford R., et al.
Publicado: (2015)

Selecting software pipelines for change in flortaucipir SUVR: Balancing repeatability and group separation
por: Schwarz, Christopher G., et al.
Publicado: (2021)

TAR DNA-Binding Protein 43 Is Associated with Rate of Memory, Functional and Global Cognitive Decline in the Decade Prior to Death
por: Buciuc, Marina, et al.
Publicado: (2021)

Amyloid- and tau-PET imaging in a familial prion kindred
por: Jones, David T., et al.
Publicado: (2018)

(18)F-FDG PET-CT pattern in idiopathic normal pressure hydrocephalus
por: Townley, Ryan A., et al.
Publicado: (2018)

The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes
por: Jack, Clifford R, et al.
Publicado: (2019)

Association of Longitudinal β-Amyloid Accumulation Determined by Positron Emission Tomography With Clinical and Cognitive Decline in Adults With Probable Lewy Body Dementia
por: Nedelska, Zuzana, et al.
Publicado: (2019)

Predicting amyloid PET and tau PET stages with plasma biomarkers
por: Jack, Clifford R, et al.
Publicado: (2023)

Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants
por: Whitwell, Jennifer L., et al.
Publicado: (2019)

Comparison of [(18)F]Flutemetamol and [(11)C]Pittsburgh Compound-B in cognitively normal young, cognitively normal elderly, and Alzheimer's disease dementia individuals
por: Lowe, Val J., et al.
Publicado: (2017)

Optimum Differentiation of Frontotemporal Lobar Degeneration from Alzheimer Disease Achieved with Cross‐Sectional Tau Positron Emission Tomography
por: Josephs, Keith A., et al.
Publicado: (2022)

β-Amyloid PET and neuropathology in dementia with Lewy bodies
por: Kantarci, Kejal, et al.
Publicado: (2020)

Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics
por: Whitwell, Jennifer L., et al.
Publicado: (2012)

Rates of transition between amyloid and neurodegeneration biomarker states and to dementia among non-demented individuals: a population-based cohort study
por: Jack, Clifford R., et al.
Publicado: (2015)

Relationships between β-amyloid and tau in an elderly population: An accelerated failure time model
por: Therneau, Terry M., et al.
Publicado: (2021)

Longitudinally Increasing Elevated Asymmetric Flortaucipir Binding in a Cognitively Unimpaired Amyloid-Negative Older Individual
por: Schwarz, Christopher G., et al.
Publicado: (2022)

Predicting future rates of tau accumulation on PET
por: Jack, Clifford R, et al.
Publicado: (2020)

Posterior cortical atrophy phenotypic heterogeneity revealed by decoding (18)F-FDG-PET
por: Townley, Ryan A, et al.
Publicado: (2021)

Disrupted functional connectivity in primary progressive apraxia of speech
por: Botha, Hugo, et al.
Publicado: (2018)

Long-term associations between amyloid positron emission tomography, sex, apolipoprotein E and incident dementia and mortality among individuals without dementia: hazard ratios and absolute risk
por: Jack, Clifford R., et al.
Publicado: (2022)

Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly
por: Vemuri, Prashanthi, et al.
Publicado: (2015)

β-Amyloid PET and (123)I-FP-CIT SPECT in Mild Cognitive Impairment at Risk for Lewy Body Dementia
por: Chen, Qin, et al.
Publicado: (2021)

A robust biomarker of large-scale network failure in Alzheimer's disease
por: Wiepert, Daniela A., et al.
Publicado: (2017)

Face recognition from research brain PET: An unexpected PET problem
por: Schwarz, Christopher G., et al.
Publicado: (2022)

Associations of quantitative susceptibility mapping with Alzheimer’s disease clinical and imaging markers
por: Cogswell, Petrice M., et al.
Publicado: (2020)

(18)F‐AV‐1451 uptake differs between dementia with lewy bodies and posterior cortical atrophy
por: Nedelska, Zuzana, et al.
Publicado: (2019)

Histologic lesion type correlates of magnetic resonance imaging biomarkers in four-repeat tauopathies
por: Carlos, Arenn F., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6oepjfe4cqf60dsoo6dffcv4rt